From June 29 to July 3, 2025, CATCO2NVERS was showcased at the 17th International Symposium on Biocatalysis and Biotransformations (Biotrans 2025), held in Basel, Switzerland. The event brought together leading scientists and innovators to discuss cutting-edge developments in biocatalysis, including enzyme engineering, discovery of novel activities, and sustainable synthesis routes. The symposium served as a key platform for the CATCO2NVERS project to connect with peers in enzymatic research and share its contributions toward CO₂-based value chains.
CATCO2NVERS was presented through a scientific poster titled “Enantioselective synthesis of D-lactic acid from CO₂ using a novel pyruvate decarboxylase in a scalable biocatalytic cascade.” This work, presented by Daan van Vliet, a researcher from Wageningen University, highlighted a promising biotransformation strategy using engineered enzymes to convert CO₂ into value-added chiral molecules. The study demonstrated both the scalability and stereoselectivity of the cascade, aligning with CATCO2NVERS’ mission to valorise CO₂ into high-value products through innovative biotechnological pathways.
The presentation attracted significant interest from experts in enzyme catalysis and CO₂ utilisation, positioning CATCO2NVERS as a forward-looking initiative at the intersection of synthetic biology and carbon circularity. Participation in Biotrans 2025 reinforced the project’s visibility in the scientific community and helped foster potential collaborations in enzyme development and bio-based CO₂ conversion technologies.
